George M. Warimwe

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2020 · 5K citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2021 · 1.2K citations · Full text

Veterinary Medicine, Immunology, Immunization +16

Seroprevalence of anti–SARS-CoV-2 IgG antibodies in Kenyan blood donors

Sophie Uyoga, Ifedayo Adetifa, Henry Karanja et al. · Science · 2020 · 352 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +12

Targets of antibodies against Plasmodium falciparum–infected erythrocytes in malaria immunity

Jo-Anne Chan, Katherine Howell, Linda Reiling et al. · Journal of Clinical Investigation · 2012 · 221 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice

Naif Khalaf Alharbi, Eriko Padron-Regalado, Craig Thompson et al. · Vaccine · 2017 · 164 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17